Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Wednesday, May 7, 2025 · 810,422,795 Articles · 3+ Million Readers

AMTB Investors Have Opportunity to Join Amerant Bancorp Inc. Fraud Investigation with the Schall Law Firm

May 07, 2025 --

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Amerant Bancorp Inc. (“Amerant” or “the Company”) (NYSE: AMTB) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Amerant reported its financial results for Q1 2025 on April 23, 2025. The Company’s earnings per share missed consensus estimates by a wide margin. The Company’s Chairman and CEO said that “loans were relatively flat quarter over quarter, as a result of increased payoffs and paydowns offsetting production in the first quarter.” Based on this news, shares of Amerant fell by more than 13% on the next day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Powered by EIN Presswire

Distribution channels:

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release